Fui Mee Ng
Experimental Drug Development Centre(SG)
Publications by Year
Research Areas
Wnt/β-catenin signaling in development and cancer, RNA Research and Splicing, Antimicrobial Peptides and Activities, Cancer-related gene regulation, Biochemical and Structural Characterization
Most-Cited Works
- → Fragment-Based Ligand Design of Novel Potent Inhibitors of Tankyrases(2013)65 cited
- → Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells(2013)51 cited
- → Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2(2020)42 cited
- → Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections(2017)40 cited
- → Pseudomonas aeruginosa develops Ciprofloxacin resistance from low to high level with distinctive proteome changes(2016)36 cited
- → Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure–activity relationship study(2015)35 cited
- → Preliminary investigations into developing all‐D Omiganan for treating Mupirocin‐resistant MRSA skin infections(2017)25 cited
- → Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole‐resistant Candida albicans(2017)23 cited
- → Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease(2016)20 cited
- → An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA)(2015)18 cited